Cited by 13Autism Spectrum Disorder ResearchMesenchymal stem cell researchGenetics and Neurodevelopmental Disorders

Cell Therapies for Autism Spectrum Disorder Based on New Pathophysiology: A Review

Open access
Nabetani, Makoto, Mukai, Takeo, Taguchi, Akihiko·2023·Cell Transplantation

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by difficulties in social communication, repetitive behaviors, and restricted interests, with onset early in life. The prevalence of ASD has increased worldwide in the last two decades. However, there is currently no effective therapy for ASD. Therefore, it is important to develop new strategies for ASD treatment. Evidence for the relationship between ASD and neuroinflammation, ASD and microglia, and ASD and glucose metabolism has increased rapidly in recent decades. We reviewed 10 clinical studies on cell therapies for individuals with ASD. Almost all studies showed good outcomes and no remarkable adverse events. Over the past decades, the neurophysiological characteristics of ASD have been shown to be impaired communication, cognition, perception, motor skills, executive function, theory of mind, and control of emotions. Recent studies have focused on the roles of immune pathology, such as neuroinflammation, microglia, cytokines, and oxidative stress, in ASD. We also focused on glucose metabolism in patients with ASD. The significance of gap junction–mediated cell–cell interactions between the cerebral endothelium and transplanted cells was observed in both bone marrow mononuclear cells and mesenchymal stromal cells transplantation. Owing to the insufficient number of samples, cell therapies, such as umbilical cord blood cells, bone marrow mononuclear cells, and mesenchymal stromal cells, will be a major challenge for ASD. As a result of these findings, a new paradigm for cell therapy for autism may emerge.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/09636897231163217

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Riordan et al. is included as a normal part of the scientific literature in articles contributing to meta-analyses and reviews or aiding interpretation of newly reported data.

    “Instead, this retracted article is included as a normal part of the scientific literature in these articles, contributing to metaanalyses and reviews of the current state of stem cell science19,20 or aiding the interpretation of newly reported data.21,22”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 6

  1. Blumberg SJ, Natl Health Stat Report, 2013
  2. Li Q, 2015, Genet Mol Res, 14
  3. Sharma AK, 2020, Am J Stem Cells, 9, 89
  4. Randall M, 2018, Cochrane Database Syst Rev, 7
  5. 10.1172/jci200420622 · DOI
  6. Anil Kumar BN, 2017, Indian J Psychol Med, 39

Cited by

Sorted by citations

Authors
Nabetani, M., Mukai, T., & Taguchi, A.
Affiliations
  • Yodogawa Christian Hospital (JP)
  • University of Tokyo Hospital (JP)
  • Foundation for Biomedical Research and Innovation (JP)
Corresponding author
Nabetani, Makoto
Venue
Cell Transplantation
Published
2023-01
Volume
32
Pages
9636897231163217-9636897231163217
ISSN
  • 0963-6897 (ISSN-L)
  • 1555-3892
OpenAlex
W4361987374
Cited by
13
References
88
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 3
FWCI
0.49
Type
journal article
Language
en
Open access
Locations
  • Cell Transplantation (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
the Japan Society for the Promotion of Science (Grant Number 21K15618)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
autism spectrum disorder, cell therapy, neuroinflammation, microglia, glucose metabolism, bone marrow mononuclear cell transplantation, mesenchymal stem cells, umbilical cord blood cells, gap junctions, brain endothelium, immunopathology, oxidative stress, cytokines, neurodevelopmental disorders
MeSH terms
Autism Spectrum Disorder, Neuroinflammatory Diseases, Cognition, Glucose, Humans, Cytokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review